Depot-based delivery systems for pro-angiogenic peptides: a review

Depot-based delivery systems for pro-angiogenic peptides: a review

Insufficient vascularization currently limits the size and complexity for all tissue engineering approaches. Additionally, increasing or re-initiating blood flow is the first step towards restoration of ischemic tissue homeostasis. However, no FDA approved pro-angiogenic treatments exist, despite th...

Full description

Bibliographic Details
Main Authors: Amy H. Van Hove, Danielle SW Benoit
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-07-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Hydrogels
Angiogenesis
Drug delivery
review
Biomaterials
Controlled Release
Online Access:http://journal.frontiersin.org/Journal/10.3389/fbioe.2015.00102/full

Similar Items

Similar Items